Babcock Gilbert Sara, Polotsky Alex J
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, United States.
Case Rep Womens Health. 2019 Jan 26;21:e00099. doi: 10.1016/j.crwh.2019.e00099. eCollection 2019 Jan.
•Intravaginal culture (IVC) is not a new technology but is gaining in popularity•The INVOcell device is marketed as a lower cost treatment option to in-vitro fertilization (IVF)•Previous studies done by the INVOcell owned company have shown similar live birth rates between INVOcell IVC and IVF•It is unclear how much of a cost savings is present with use of IVC compared to traditional IVF•IVC may represent a viable option for fertility treatment in select patients.
•阴道内培养(IVC)并非新技术,但正越来越受欢迎
•INVOcell装置作为体外受精(IVF)成本更低的治疗选择进行销售
•INVOcell所属公司之前进行的研究表明,INVOcell IVC和IVF的活产率相似
•与传统IVF相比,使用IVC能节省多少成本尚不清楚
•IVC可能是某些特定患者生育治疗的可行选择。